Comorbidities & Rheumatoid Arthritis – study findings

A recent Canadian study examining comorbidities before and after the diagnosis of rheumatoid arthritis (RA) produced a number of interesting findings, Dr Mark Tatangelo, the lead researcher explains.

___

Keep up to date with us across our network:

This content is for informational purposes only, and does not replace the advice of your own doctor or healthcare professional. Copyright © 2021 MedicalUpdateOnline.

IMI (a trading name of ICR UK Limited) is a digital communications agency that specialises in the pharmaceutical and medical industries.

IMI was founded in 2003 by the current CEO Peter Mas-Mollinedo, a pharmacist and forward-thinking entrepreneur. IMI’s primary activities include the production of medical educational journals and bulletins, medical conference coverage and video interviewing of health care professionals worldwide to disseminate information such as trial results, new products, research, drug approvals, new accreditations, etc.

It is a trusted provider of medical information to its extensive database of medical health care professionals in the UK, Europe and beyond.